Our meta-analysis (32,541 older adults) shows SGLT-2 inhibitors significantly reduce mortality, heart failure hospitalizations, and major cardiac events.
Yet, they remain underused. Why? 🧵👇
#CardioSky
Our meta-analysis (32,541 older adults) shows SGLT-2 inhibitors significantly reduce mortality, heart failure hospitalizations, and major cardiac events.
Yet, they remain underused. Why? 🧵👇
#CardioSky